Annual or Index Following is the author index for volume 168 of the Journal, which covers all material from January 2011 through December 2011. The Journal no longer prints a subject index. Two-letter abbreviations are used for months. The complete citation for each article is listed under the name of the first author. Coauthors are listed alphabetically with a cross-reference to the first author; cross-references containing multiple first au- thor names separated by semicolons indicate multiple articles by the coauthor. Entries other than Reviews and Overviews and New Research are given the following designations: Commentary (commentary), Editorial (editorial), Images in Neuroscience (image, neuro), Introspections (introspections), Treatment in Psychiatry (treatment in psychiatry), Clinical Case Conference (case conf), Education in Psychiatry (education in psychia- try), Images in Psychiatry (image, psych), Book Forum (bk rev), Letters to the Editor (letter), Official Actions (off acts), and Supplement (suppl). Corrections are cited with the articles to which they refer. Readers can also use the Journal's website (ajp.psychiatryonline.org) to search by author, issue, subject, section, or keyword. A Alliey-Rodriguez N see Ger- Arion D see Curley AA Beevers CG, Lee H-J, Wells TT, shon ES Armario A see Andero R Ellis AJ, Telch MJ: Associa- Aarts E see Hoogman M Alpert JE see Wickramaratne Arseneault L, Cannon M, tion of predeployment gaze Acquaviva C see FassierT P Fisher HL, Polanczyk G, bias for emotion stimuli with Adam Es ee Allen MH Altshuler KZ: bk rev, Clarkin Moffitt TE, Caspi A: Child- later symptoms of PTSD Addington J, Cornblatt BA, JE Fonagy P. Gabbard GO, hood trauma and children’s and depression in soldiers Cadenhead KS, Cannon TD, eds: Psychodynamic Psy- emerging psychotic symp- deployed in Iraq. Jy 735-741 McGlashan TH, Perkins DO, chotherapy for Personality toms: a genetically sensitive Ben-Zeev D see Swendsen J Seidman LJ, Tsuang MT, Disorders. Ja 101-102 longitudinal cohort study. Ja Benros ME, Nielsen PR, Walker EF, Woods SW, Heins- Altshuler LL see Foland-Ross 65-72 Nordentoft M, Eaton WW, sen R: At clinical high risk LC Asafu-Adjei JK see Curley AA Dalton SO, Mortensen PB: for psychosis: outcome for Alvaro JL see De Nadai AS Auberson YP see Deschwan- Autoimmune diseases and nonconverters. Au 800-805 Alzheimer’s Disease Neu- denA severe infections as risk Adler JM: Epistemological roimaging Initiative see Aubin H-J, Berlin I, Reyn- factors for schizophrenia: a tension in the future of per- Thompson WK aud M: Current smoking, 30-year population-based sonality disorder diagnosis American Board of Psychi- hypoxia, and suicide (letter). register study. De 1303-1310 (letter). No 1221-1222 atry and Neurology: 2010 Mr 326-327 Bergen SE see Levinson DF Agarwal LJ, Berger CE, Gill L: Annual Report (off acts). Au Auther AM see Carri6n RE Berger CE see Agarwal LJ Naltrevone for severe self- 863-868 Avery JD, Savitz AJ: A novel Bergquist K see Rando K harm behavior: a case report American Psychiatric Asso- use of dignity therapy (let- Berlin I see Aubin H-J (letter). Ap 437-438 ciation: APA council reports ter). De 1340 Berner LA see Marsh R Aggen SH see Kendler KS (off acts). Fe 219-226 Azad A, Martin A: The Yale Bernstein CA: Presidential Ad- Agorastos A, Huber CG, American Psychiatric As- Child Study Center centen- dress: transforming mental Dunker S, Wiedemann K: sociation: Reports to the nial: 1911-2011 (image, health through leadership, Reduced pain perception membership (off acts). Se psych). Fe 123 discovery, and collaboration. in schizophrenia: a case of 998-1004 Oc 1021-1025 an undetected intrathoracic Ametamey SM see Deschwan- Bernstein J, Friedman RA: pencil (letter). Au 854-855 denA Lithium-associated hyper- Agrawal A see Pergadia ML Amin F see Levinson DF Baandrup L: How dosing thyroidism treated with Ahlf K see Foland-Ross LC Andero R, Heldt SA, Ye K, Liu might influence the conclu lithium withdrawal: a case Ait-Daoud N see Johnson BA X, Armario A, Ressler KJ: Ef- sion in an antipsychotic report (letter). Ap 438-439 Aizenstein HJ, Andreescu C, fect of 7,8-dihydroxyflavone, polypharmacy effectiveness Bernstein LF: bk rev, Simon Edelman KL, Cochran JL, a small-molecule TrkB ago- trial (letter). Oc 1117 RI, Gold LH, eds: The Ameri- Price J, Butters MA, Karp nist, on emotional learning Bakalkin G see Dong L can Psychiatric Publish- J, Patel M, Reynolds CF III: Fe 163-172 Baldessarini RJ see Viguera ing Textbook of Forensic fMRI correlateosf white Andersson G see Cuijpers P AC Psychiatry, Second Edition. matter hyperintensities Andreassen OA see Ingason A Baldwin RM see Woodward Fe 215-216 in late-life depression. Oc Andreescu C see Aizenstein HJ ND Bhagwagar Z see Rando K 1075-1082 Ansari MS see Woodward ND Banas R see Miiller CA Biederman J see Surman GBH Ak M see Naharci MI Anton RE, Myrick H, Wright BanaschewskiT see Peters J Bienfait KL see Dobkin RD Albrecht U see Dong L TM, Latham PK, Baros Barale A, Emmanuele E, Politi Bilbao A see Dong L Alcon J, Glazier K, Rodriguez AM, Waid LR, Randall PK: P: Aby Warburg, 1866-1929 Binder EB see Zimmermann P C: From clutter to mod Gabapentin combined with (image, psych). Au 782 Binswanger I see Nussbaum A ern art: a Chinese artist's naltrexone for the treatment Barber JP see Gerber AJ Birmaher B: Remission of perspective on hoarding of alcohol dependence. Jy Barglow P, MurphyT: An early a mother’s depression is behaviors (image, psych) 709-717 Greek portrayal of a mad associated with her child’s De 1248 Appelbaum P%S: bk rev, van Vo- mind (image, psych). Se 893 mental health (editorial). Je Allen LA see Dobkin RD ren R: Cold War in Psychia- Baros AM see Anton RF 563-565 Allen MH, Debanné M, try: Human Factors, Secret Bassett AS see Chow EWC Black DW see Levinson DF Lazignac C, Adam E, Actors. Mr 333-334 Bassett AS: Parental origin, Black KJ: A new (old) treat- Dickinson LM, Damsa C: Appenzeller GN see Warner DNA structured, and the ment option for depression Effect of nicotine replace CH schizophrenia spectrum in Parkinson's disease (edito- ment therapy on agitation in Arias SA, Cohen P, Kwon JS: (editorial). Ap 350-353 rial). Oc 1015-1016 smokers with schizophrenia Clozapine-induced lympho Bauer LK see Mukherji EH Blair KS see Finger EC a double-blind, randomized, cytic alveolitis (letter). Fe Bearden CE see Mittal VA Blair KS, Geraci M, Hollon N, placebo-controlled study. Ap 210-211 Beck AT see Shedler J Otero M, DeVido J, Majestic 395-399 Arias-Vasquez A see Bralten J Beenhakker J see Lock J C, Jacobs M, Blair RJR, Pine 1352 ajp.psychiatryonline.org Am | Psychiatry 168:12, December 2011 Annual or Index Following is the author index for volume 168 of the Journal, which covers all material from January 2011 through December 2011. The Journal no longer prints a subject index. Two-letter abbreviations are used for months. The complete citation for each article is listed under the name of the first author. Coauthors are listed alphabetically with a cross-reference to the first author; cross-references containing multiple first au- thor names separated by semicolons indicate multiple articles by the coauthor. Entries other than Reviews and Overviews and New Research are given the following designations: Commentary (commentary), Editorial (editorial), Images in Neuroscience (image, neuro), Introspections (introspections), Treatment in Psychiatry (treatment in psychiatry), Clinical Case Conference (case conf), Education in Psychiatry (education in psychia- try), Images in Psychiatry (image, psych), Book Forum (bk rev), Letters to the Editor (letter), Official Actions (off acts), and Supplement (suppl). Corrections are cited with the articles to which they refer. Readers can also use the Journal's website (ajp.psychiatryonline.org) to search by author, issue, subject, section, or keyword. A Alliey-Rodriguez N see Ger- Arion D see Curley AA Beevers CG, Lee H-J, Wells TT, shon ES Armario A see Andero R Ellis AJ, Telch MJ: Associa- Aarts E see Hoogman M Alpert JE see Wickramaratne Arseneault L, Cannon M, tion of predeployment gaze Acquaviva C see FassierT P Fisher HL, Polanczyk G, bias for emotion stimuli with Adam Es ee Allen MH Altshuler KZ: bk rev, Clarkin Moffitt TE, Caspi A: Child- later symptoms of PTSD Addington J, Cornblatt BA, JE Fonagy P. Gabbard GO, hood trauma and children’s and depression in soldiers Cadenhead KS, Cannon TD, eds: Psychodynamic Psy- emerging psychotic symp- deployed in Iraq. Jy 735-741 McGlashan TH, Perkins DO, chotherapy for Personality toms: a genetically sensitive Ben-Zeev D see Swendsen J Seidman LJ, Tsuang MT, Disorders. Ja 101-102 longitudinal cohort study. Ja Benros ME, Nielsen PR, Walker EF, Woods SW, Heins- Altshuler LL see Foland-Ross 65-72 Nordentoft M, Eaton WW, sen R: At clinical high risk LC Asafu-Adjei JK see Curley AA Dalton SO, Mortensen PB: for psychosis: outcome for Alvaro JL see De Nadai AS Auberson YP see Deschwan- Autoimmune diseases and nonconverters. Au 800-805 Alzheimer’s Disease Neu- denA severe infections as risk Adler JM: Epistemological roimaging Initiative see Aubin H-J, Berlin I, Reyn- factors for schizophrenia: a tension in the future of per- Thompson WK aud M: Current smoking, 30-year population-based sonality disorder diagnosis American Board of Psychi- hypoxia, and suicide (letter). register study. De 1303-1310 (letter). No 1221-1222 atry and Neurology: 2010 Mr 326-327 Bergen SE see Levinson DF Agarwal LJ, Berger CE, Gill L: Annual Report (off acts). Au Auther AM see Carri6n RE Berger CE see Agarwal LJ Naltrevone for severe self- 863-868 Avery JD, Savitz AJ: A novel Bergquist K see Rando K harm behavior: a case report American Psychiatric Asso- use of dignity therapy (let- Berlin I see Aubin H-J (letter). Ap 437-438 ciation: APA council reports ter). De 1340 Berner LA see Marsh R Aggen SH see Kendler KS (off acts). Fe 219-226 Azad A, Martin A: The Yale Bernstein CA: Presidential Ad- Agorastos A, Huber CG, American Psychiatric As- Child Study Center centen- dress: transforming mental Dunker S, Wiedemann K: sociation: Reports to the nial: 1911-2011 (image, health through leadership, Reduced pain perception membership (off acts). Se psych). Fe 123 discovery, and collaboration. in schizophrenia: a case of 998-1004 Oc 1021-1025 an undetected intrathoracic Ametamey SM see Deschwan- Bernstein J, Friedman RA: pencil (letter). Au 854-855 denA Lithium-associated hyper- Agrawal A see Pergadia ML Amin F see Levinson DF Baandrup L: How dosing thyroidism treated with Ahlf K see Foland-Ross LC Andero R, Heldt SA, Ye K, Liu might influence the conclu lithium withdrawal: a case Ait-Daoud N see Johnson BA X, Armario A, Ressler KJ: Ef- sion in an antipsychotic report (letter). Ap 438-439 Aizenstein HJ, Andreescu C, fect of 7,8-dihydroxyflavone, polypharmacy effectiveness Bernstein LF: bk rev, Simon Edelman KL, Cochran JL, a small-molecule TrkB ago- trial (letter). Oc 1117 RI, Gold LH, eds: The Ameri- Price J, Butters MA, Karp nist, on emotional learning Bakalkin G see Dong L can Psychiatric Publish- J, Patel M, Reynolds CF III: Fe 163-172 Baldessarini RJ see Viguera ing Textbook of Forensic fMRI correlateosf white Andersson G see Cuijpers P AC Psychiatry, Second Edition. matter hyperintensities Andreassen OA see Ingason A Baldwin RM see Woodward Fe 215-216 in late-life depression. Oc Andreescu C see Aizenstein HJ ND Bhagwagar Z see Rando K 1075-1082 Ansari MS see Woodward ND Banas R see Miiller CA Biederman J see Surman GBH Ak M see Naharci MI Anton RE, Myrick H, Wright BanaschewskiT see Peters J Bienfait KL see Dobkin RD Albrecht U see Dong L TM, Latham PK, Baros Barale A, Emmanuele E, Politi Bilbao A see Dong L Alcon J, Glazier K, Rodriguez AM, Waid LR, Randall PK: P: Aby Warburg, 1866-1929 Binder EB see Zimmermann P C: From clutter to mod Gabapentin combined with (image, psych). Au 782 Binswanger I see Nussbaum A ern art: a Chinese artist's naltrexone for the treatment Barber JP see Gerber AJ Birmaher B: Remission of perspective on hoarding of alcohol dependence. Jy Barglow P, MurphyT: An early a mother’s depression is behaviors (image, psych) 709-717 Greek portrayal of a mad associated with her child’s De 1248 Appelbaum P%S: bk rev, van Vo- mind (image, psych). Se 893 mental health (editorial). Je Allen LA see Dobkin RD ren R: Cold War in Psychia- Baros AM see Anton RF 563-565 Allen MH, Debanné M, try: Human Factors, Secret Bassett AS see Chow EWC Black DW see Levinson DF Lazignac C, Adam E, Actors. Mr 333-334 Bassett AS: Parental origin, Black KJ: A new (old) treat- Dickinson LM, Damsa C: Appenzeller GN see Warner DNA structured, and the ment option for depression Effect of nicotine replace CH schizophrenia spectrum in Parkinson's disease (edito- ment therapy on agitation in Arias SA, Cohen P, Kwon JS: (editorial). Ap 350-353 rial). Oc 1015-1016 smokers with schizophrenia Clozapine-induced lympho Bauer LK see Mukherji EH Blair KS see Finger EC a double-blind, randomized, cytic alveolitis (letter). Fe Bearden CE see Mittal VA Blair KS, Geraci M, Hollon N, placebo-controlled study. Ap 210-211 Beck AT see Shedler J Otero M, DeVido J, Majestic 395-399 Arias-Vasquez A see Bralten J Beenhakker J see Lock J C, Jacobs M, Blair RJR, Pine 1352 ajp.psychiatryonline.org Am | Psychiatry 168:12, December 2011 ANNUAL AUTHOR INDEX DS: Response to Hubbeling: volunteers? (commentary). ing attenuated psychosis motor developmental delay Alternative explanation for De 1245-1247 syndrome criteria (letter). and obstetric complications: fMRI findings in social pho- Broft A see Martinez D No 1221 evidence from a population- bia (letter). My 551-552 Brohawn KH see Shin LM Carpenter WT, van Os J: based longitudinal study. De Blair KS, Geraci M, Korelitz K, Bromberg U see Peters J Should attenuated psycho- 1295-1302 (correction: De Otero M, Towbin K, Ernst M, Bromet EJ, Kotov R, Focht- sis syndrome be a DSM-5 1345) Leibenluft E, Blair RJR, Pine mann LJ, Carlson GA, diagnosis? (commentary). Clarke T-K see Dong L DS: The pathology of social Tanenberg-Karant M, Rug- My 460-463 Clasen L see Mattai A phobia is independent of de- gero C, Chang S-w: Diagnos- Carrion RE, Goldberg TE, Claustrat B see Quera-Salva velopmental changes in face tic shifts during the decade McLaughlin D, Auther AM, M-A processing. No 1202-1209 following first admission for Correll CU, Cornblatt BA: Cloninger CR see Levinson DF Blair RJR see Blair KS; Finger psychosis. No 1186-1194 Impact of neurocognition Cochran JL see Aizenstein HJ EC Broms U see Pergadia ML on social and role function- Cohen BE see Duivis HE Blanco C: bk rev, Shrout PE, Brook DW: bk rev, Kaminer ing in individuals at clinical Cohen P: Abuse in childhood Keyes KM, Ornstein K: Cau- Y, Winters KC, eds: Clini- high risk for psychosis. Au and the risk for psychotic sality and Psychopathology: cal Manual of Adolescent 806-813 symptoms in later life (edito- Finding the Determinants of Substance Abuse Treatment. Carroll KM see Kiluk BD rial). Ja 7-8 Disorders and Their Cures. Au 859-860 Carter CS see Ursu S Cohen SA see Arias SA Au 858-859 Brown AS: Further evidence Caspi A see Zimmermann P Cohen SK: bk rev, Gold LH, Blazer D see Cooper C of infectious insults in the Caton CLM see Drake RE Shuman DW: Evaluating Blomeyer D see Dong L pathogenesis and patho- Cella M see Raballo A Mental Health Disability Bonazza S see Marconi S physiology of schizophrenia Cellard C see Wykes T in the Workplace: Model, Bonetto C see Ingason A (editorial). Au 764-766 Cerda G see Wickramaratne P Process, and Analysis. Ap Bookheimer SY see Foland- Brown GK see Posner K Chamberlain SR see Grant JE 441-442 Ross LC Briickl T see Zimmermann P Chan CH: bk rev, Bhugra D, Cohen-Woods § see Breen G Boomsma DI see Pergadia ML Brugiéres L see Quera-Salva Malik A, Ikkos G, eds: Psychi- Cohler BJ see Grunebaum H Borenstein J: The Council on M-A atry’s Contract with Society: ColibazziT see Wang Z Communications (off acts). Brunner HG see Bralten J Concepts, Controversies, and Collier DA see Ingason A Fe 221-222 Brzustowicz L, Freedman Consequences. No 1227 Comer JS, Mojtabai R, Olfson Bose SK see Howes OD R: Digging more deeply for Chan RCK see LuiS M: National trends in the Bozoglu E see Naharci MI generic effects in psychi- Chang S-S, Page A, Gunnell D: antipsychotic treatment Braff DL see Greenwood TA atric illness (editorial). Oc Internet searches for a spe of psychiatric outpatients Bralten J, Arias-Vasquez A, 1017-1020 cific suicide method follow with anxiety disorders. Oc Makkinje R, Veltman JA, Buccola NG see Levinson DF its high-profile media cover- 1057-1065 Brunner HG, Fernandez G, Biichel C see Peters J age (letter). Au 855-857 Compton MT see Druss BG Rijpkema M, Franke B: As- Buck A see Deschwanden A Chang S-w see Bromet EJ Conrod P] see Peters J sociation of the Alzheimer's Buckley PJ: bk rev, Wal- Chapman MR, Vause HE: An- Cook IA see Rush AJ gene SORL] with hippocam- lace DF: A Supposedly Fun ti-N MDA receptor encepha- Cools R see Hoogman M pal volume in young, healthy hing I'll Never Do Again: litis: diagnosis, psychiatric Cooper C, Katona C, Lyketsos adults. Oc 1083-1089 Essays and Arguments. De presentation, and treatment K, Blazer D, Brodaty H, Brassen S see PetersJ 1341-1342 (case conf). Mr 245-251 Rabins P, de Mendonca Lima Breen G, Webb BT, Butler AW, Buckley PJ: Paul Cézanne, Chapman MR, Vause HE: CA, Livingston G: A system- van den Oord EJG, Tozzi F, 1839-1906 (image, psych). Response to Dhossche, Fink, atic review of treatments Craddock N, Gill M, Korszun Jy 680 Shorter, Wachtel: Anti- for refractory depression in A, Maier W, Middleton L, Buitelaar J see Hoogman M NMDA receptor encephalitis older people (reviews and Mors O, Owen MJ, Cohen- Buitelaar JK see Poelmans G versus pediatric catatonia overviews). Jy 681-688 Woods §, Perry J, Galwey Burger C see Deschwanden A (letter). Jy 750-751 Coors ME: bk rev, Peay H, NW, Upmanyu R, CraigI Burke AK see Oquendo MA Charach R: bk rev, Ablon Austin J: How to Talk with Lewis CM, Ng M, Brewster S, Bush G see Shin LM SL: Night Call Poems. De Families About Genetics Preisig M, Rietschel M, Jones Butler AW see Breen G 1343-1344 and Psychiatric Illness. Se L, Knight J, Rice J, Muglia Butters MA see Aizenstein HJ Charman T: The highs and 994-995 P, Farmer AE, McGuffin P: Byerley WF see Levinson DF lows of counting autism Cornblatt BA see Addington J; A genome-wide significant (editorial). Se 873-875 Carrién RE linkage for severe depres- Cc Cheng Y-C see Wu C-S Correa PR: Limitations of ret- sion on chromosome 3: the Cheon K-A see Kim YS rospective research (letter). Depression Network study. Cabaj RP: The Council on Chessick C see Snavely A Ap 436-437 Au 840-847 Advocacy and Govern- Chisolm MS see Spencer L Correll CU see Carrién RE Breier A: Anxiety disorders ment Relations (cff acts). Fe Chou Y-L see Pergadia ML Corruble E see Gressier F and antipsychotic drugs: 219-220 Chow EWC, Ho A, Wei C, Cortelli P see Marconi S a pressing need for more Cadenhead KS see Addington Voormolen EHJ, Crawley Coryell W: Diagnostic instabil research (editorial). Oc J; Greenwood TA AP, Bassett AS: Association ity: how much is too much? 1012-1014 Calder AJ see Fairchild G of schizophrenia in 22q11.2 (editorial). No 1136-1138 Brenner BE see Kim N Calkins ME see Greenwood TA deleticn syndrome and gray Coryell W: The search for Brent DA see Posner K Cannon Ms ee Arseneault L; matter volumetric deficits in improved antidepressant Brent D: Nonsuicidal self- Clarke MC the superior temporal gyrus. strategies: is bigger better? injury as a predictor of sui- Cannon TD see Addington J; My 522-529 (editorial). Jy 664-666 cidal behavior in depressed Mittal VA Chu BC see Mark TL Coryell WH see Fiedorowicz JG adolescents (editorial). My Capellari S see Marconi S Cichon S see Dong L; Ingason Cété SM see Pingault J-B 452-454 Carbonneau Rs ee Pingault A Covell NH see Essock SM Brewster S see Breen G J-B Clarke MC, Tanskanen A, Covell NH, McEvoy JP, Stroup Brodaty H see Cooper C Carlson GA see Bromet EJ Huttunen M, Leon DA, TS, Schooler NR, Essock Brody B, Leon AC, Kocsis JH: Carpenter KM see Martinez D Murray RM, Jones PB, Can- SM: Response to Baandrup: Antidepressant clinical trials Carpenter WT, van Os J: Re- non M: Increased risk of How dosing might influ- and subject recruitment: sponse to Rietdijk, Linszen, schizophrenia from additive ence the conclusion in an just who are symptomatic van der Gaag: Field test- interaction between infant antipsychotic polypharmacy Am | Psychiatry 168:12, December 2011 ajp.psychiatryonline.org 1353 ANNUAL AUTHOR INDEX effectiveness trial (letter). risk for PTSD (editorial). Ja Kosten TR: Response to E Oc 1117 9-11 Lustman, Svrakic, Freedland: Cowan RL see Woodward ND Delespaul P see Heins M Preventing pain medica- Eack SM see Prasad KM Cox BS see Cox DJ Demir O see Naharci MI tion dependence (letter). Oc Eaton WW see Benros ME Cox DJ, Cox B, Cox J: Self- Dempster E see Ingason A 1118-1119 Eddy KT, Rauch SL: Neuro- reported incidences of mov- Denier C see Gressier F Dokey A see Spencer L imaging in eating disorders: ing vehicle collisions and Denk MC, Rewerts C, Hols- Domenech Ps ee Fassier T coming of age (editorial). No citations among drivers with boer F, Erhardt-Lehmann A, Dong L, Bilbao A, Laucht M, 1139-1141 ADHD: a cross-sectional Turck CW: Monitoring ket- Henriksson R, Yakovleva Edelman KL see Aizenstein HJ survey across the lifespan amine treatment response T, Ridinger M, Desrivieres Egerton A see Howes OD (letter). Mr 329-330 in a depressed patient via S, Clarke T-K, Lourdusamy Ehardt-Lehmann A see Denk Cox J see Cox DJ peripheral mammalian tar- A, Smolka MN, Cichon MC Craddock N see Breen G; get of rapamycin activation S, Blomeyer D, Treutlein Ellis AJ see Beevers CG Ingason A (letter). Jy 751-752 J, Perreau-Lenz S, Witt Emmanuele E see Barale A Craig I see Breen G Dequardo JR: bk rev, Abou- S, Leonardi-Essmann Ff, Endicott J see Fiedorowicz JG Crawley AP see Chow EWC jaoude E, Koran LM, eds: Wodarz N, Zill P, Soyka M, Endrass T see Riesel A Csernansky JG, Smith MJ: Impulse Control Disorders. Albrecht U, Rietschel M, Eng SM see Strom BL Thought, feeling, and action No 1225-1226 Lathrop M, Bakalkin G, Epstein DH see Zhang X-l in real time—monitoring of Deschwanden A, Karolewicz Spanagel R, Schumann Ernst M see Blair KS drug use in schizophrenia B, Feyissa AM, Treyer V, G: Effects of the circadian Essock SM see Covell NH (editorial). Fe 120-122 Ametamey SM, Johayem rhythm gene period 1 (Per!) Essock SM, Hogan MF: Look- Cucchiaro J see Meltzer HY A, Burger C, Auberson YP, on psychosocial stress- ing into the health reform Cuffe S: The Council on Sovago J, Stockmeier CA, induced alcohol drinking. Oc crystal bail: seeing more Children, Adolescents, and Buck A, Hasler G: Reduced 1090-1098 constructive, less expensive Their Families (off acts). Fe metabotropic glutamate Donix M: From a clinician's management scenarios (edi- 220-221 receptor 5 density in major perspective (letter). Ap 436 torial). My 449-451 Cuijpers P, Geraedts AS, van depression determined by Donohue JM see Garfield RL Essock SM, Schooler NR, Oppen P, Andersson G, (''C|ABP688 PET and post- Doop M see Woodward ND Stroup T, McEvoy JP, Rojas Markowitz JC, van Straten A: mortem study. Jy 727-734 Doruk H see Naharci MI I, Jackson C, Covell NH, Interpersonal psychotherapy Desrivieres S see Dong L Douglas CJ: Studying the The Schizophrenia Trials for depression: a meta-anal- Devanand DP, Schultz SK: efficacy of psychodynamic Network: Effectiveness of ysis (reviews and overviews). Consequences of antipsy- psychotherapy (letter). Je 649 switching form antipsychotic Je 581-592 (correction, Je chotic medication for the Drake RE, Caton CLM, Xie polypharmacy to monother- 652) dementia patient (editorial). H, Hsu E. Gorroochurn apy. Jy 702-708 Cummings JR, Druss BG: bk Au 767-769 P, Samet S, Hasin DS: A Etkin A, Schatzberg AF: rev, Stevens RA, Rosenberg DeVido J see Blair KS prospective 2-year study Common abnormalities and CE, Burns LR, eds: History Dhossche D, Fink M, Shorter of emergency department disorder-specific compen- and Health Policy in the E, Wachtel LE: Anti- NMDA patients with early-phase sation during implicit regula- United States: Putting the receptor encephalitis versus primary psychosis or tion of emotional processing Past Back In. No 1224-1225 pediatric catatonia (letter). Jy substance-induced psycho- in generalized anxiety and Curley AA, Arion D, Volk DW, 749-750 sis. Jy 742-748 major depressive disorders. Asafu-Adjei JK, Sampson Diao H see LiM Druss BG see Cummings JR Se 968-978 AR, Fish KN, Lewis DA: Cor- Dias RS, Lafer B, Joffe H: Re- Druss BG, von Esenwein SA, Evans A see Shaw P tical deficits of glutamic acid sponse to Harvey, Kornstein: Compton MT, Zhao L, Leslie Everett A: The Council on decarboxylase 67 expression Determination of premen- DL: Budget impact and Healthcare Systems and in schizophrenia: clinical, strual symptom exacerba- sustainability of medical care Financing (CHSF) (off acts). protein, and cell type-specif- tions (letter). Se 989-990 management for persons Fe 222 ic features. Se 921-929 Dias RS, Lafer B, Russo C, Del with serious mental illnesses. Currier D see Oquendo MA Debbio A, Nierenberg AA, No 1171-1178 FE Currier GW see Posner K Sachs GS, Joffe H: Longitu- Duan J see Levinson DF Czobor P see Wykes T dinal follow-up of bipolar Dubicka B see Wilkinson P Faich G see Strom BL disorder in women with Dubovsky SL: bk rev, Light Fairchild G, Passamonti D premenstrual exacerbation: DW, ed: The Risks of L, Hurford G, Hagan CC, findings from STEP-BD. Ap Prescription Drugs. Oc von dem Hagen EAH, van Dagerman KS see Vigen CLP 386-394 1124-1125 Goozen SHM, Goodyer IM, D’Agostino RB see Strom BL Dickinson LM see Allen MH Ducreux D see Gressier F Calder AJ: Brain structure Dalton SO see Benros ME DiClemente CC see Johnson Dudbridge F see Levinson DF abnormalities in early-onset D’Amato T see Fassier T BA Duivis HE, de Jonge P, Pen- and adolescent-onset con- Damsa C see Allen MH DierksT see Homan P ninx BW, Na BY, Cohen B, duct disorder. Je 624-633 David A see Tsuang D Dixon L see Goff DC Whooley MA: Depressive Falissard B see Pingault J-B de Geus EJC see Pergadia ML Djurovic S see Ingason A symptoms, health behaviors, Fanous AH see Levinson DF de Jonge P see Duivis HE Dobie DJ see Greenwood TA and subsequent inflamma- Faraone SV see Surman GBH de Mendonga Lima CA see Dobkin RD, Menza M, Allen tion in patients with coro- Farmer AE see Breen G Cooper C LA, Gara MA, Mark MH, Tiu nary heart disease: prospec- Fassier T, Guffon N, Acqua- De Nadai AS, Storch EA, J, Bienfait KL, Friedman J: tive findings from the Heart viva C, D’Amato T, Durand Alvaro JL: Development Cognitive-behavioral therapy and Soul Study. Se 913-920 DV, Domenech P: Misdiag- of obsessive-compulsive for depression in Parkinson's Duncan LE, Keller MC: A nosed postpartum psychosis disorder following a pineal disease: a randomized, con- critical review of the first 10 revealing a late-onset urea germinoma: a Case report trolled trial. Oc 1066-1074 years of candidate gene- cycle disorder (case conf). Je (letter). My 550 Dodrill CL, Helmer DA, by-environment interac- 576-580 de Wit S see Gillan CM Kosten TR: Prescription pain tion research in psychiatry Fassler D: Report of the Trea- Debanné M see Allen MH medication dependence (reviews and overviews). Oc surer: financial status (off Del Debbio A see Dias RS (treatment in psychiatry). My 1041-1049 acts). Se 999-1000 Deiahanty DL: Toward the 466-471 Dunker S see Agorastos A Fava M see Rush AJ; Wickra- predeployment detection of Dodrill CL, Helmer DA, Durand DV see Fassier T maratne P 1354 ajp.psychiatryonline.org AmJ Psychiatry 168:12, December 2011 ANNUAL AUTHOR INDEX Federspiel A see Homan P Frese FJ see Green MF searching for genetic risk for SR: Evaluation of function- Fenton L: bk rev, Frankland Friedman AC see Martinez D schizophrenia and bipolar ally meaningful measures AG: The Little Psychotherapy Friedman J see Dobkin RD disorder (reviews and over- for clinical trials of cognition Book: Object Relations in Friedman RA see Bernstein J views). Mr 253-256 enhancement in schizophre- Practice. Ja 102 Fromson JA: The Asclepius: Geuze E see van Zuiden M nia. Ap 400-407 Fenton L: bk rev, Hall SS: the ancient standard of phy- Giacobbe P see Kennedy SH Greenberg RM: bk rev, Gallo Wisdom: From Philosophy to sicians (letter). Jy 752 Gibbons CJ see Kiluk BD R: Freud's Mexico: Into the Neuroscience. De 1343 Frost M see Marcus RM Gibson TM see Mark TL Wilds of Psychoanalysis. Ap Fernandez G see Bralten J Giedd J see Shaw P 440-441 Feyissa AM see Deschwanden G Giegling I see Ingason A Greenhill L see Posner K A Gill L see Agarwal LJ Greenstein D see Mattai A; Fiedorowicz JG, Endicott Gabbard GO see Shedler J Gill M see Breen G Shaw P J, Leon AC, Solomon DA, Galfalvy HC see Oquendo MA Gillan CM, Papmeyer M, Greenwood TA, Lazzeroni LC, Keller MB, Coryell WH: Sub- Gallinat J see Peters J Morein-Zamir S, Sahakian Murray SS, Cadenhead KS, threshold hypomanic symp- Galwey NW see Breen G BJ, Fineberg NA, Robbins Calkins ME, Dobie DJ, Green toms in progression from Gameroff MJ see Wickrama- TW, de Wit S: Disruption in ME, Gur RE, Gur RC, Hardi- unipolar major depression to ratne P the balance between goal- man G, Kelsoe JR, Leonard S, bipolar disorder. Ja 40-48 Gara MA see Dobkin RD directed behavior and habit Light GA, Nuechterlein KH, Fineberg NA see Gillan CM Garavan H see Peters J learning in obsessive-com- Olincy A, Radant AD, Schork Finger EC, Marsh AA, Blair Garber J see Wickramaratne P pulsive disorder. Jy 718-726 NJ, Seidman LJ, Siever LJ, KS, Reid ME, Sims C, Ng P, Gard MG see Ursu S Gilliam M see Shaw P Silverman JM, Stone WS, Pine DS, Blair RJR: Disrupt- Garfield RL, Zuvekas SH, Gitlin MJ see Subotnik KL Swerdlow NR, Tsuang DW, ed reinforcement signaling Lave JR, Donohue JM: The Glazier K see Alcon J Tsuang MT, Turetsky BI, in the orbitofrontal cortex impact of national health Glenthoj BY see Ingason A Freedman R, Braff DL: and caudate in youths with care reform on adults with Glowinski AL see Pergadia ML Analysis of 94 candidate conduct disorder or opposi- severe mental disorders. My Goate AM see Pergadia ML genes and 12 endopheno- tional defiant disorder and 486-494 Goff DC, Dixon L: Antipsy- types for schizophrenia a high level of psychopathic Garrett A see Lock J chotic polypharmacy: are from the Consortium on the traits. Fe 152-162 Garrett A, Kelly R, Gomez R, two ever better than one? Genetics of Schizophrenia. Fink M see Dhossche D Keller J, Schatzberg AF, Reiss (editorial). Jy 667-669 Se 930-946 FischerJ see Foland-Ross LC AL: Aberrant brain activation Gogtay N see Mattai A Greissier F, Khlif H, Denier Fish KN see Curley AA during a working memory Gold AL see Shin LM C, Hardy P, Ducreux D, Fisher HL see Arseneault L task in psychotic major 30ld JM: Imaging emotion in Corruble E: Drug-resistant Fishman MJ, Wu L-T, Woody depression. Fe 173-182 schizophrenia: not finding major depression associated GE: Buprenorphine for pre- Gaspi A see Arseneault L feelings in all the right places with carotid artery stenosis scription opioid addiction Gaston JO: Report of the (editorial). Mr 237-239 (letter). Ap 439 in a patient with depression Committee on Bylaws (off Goldberg TE see Carri6n RE Grilo CM see Skodol AE and alcohol dependence acts). Se 1002 Goldner WS see Rosenthal LJ Grinker RR see Kim YS (case conf). Jy 675-679 Gau SS-F see Wu C-S Golman D: Molecular etiolo- Grinker RR: bk rev, Mnookin Flor H see Peters J Gau SS-F: Childhood trajecto- gies of schizophrenia: are we S: The Panic Virus: A True Flury R see Homan P ries of inattention symptoms almost there yet? (editorial). Story of Medicine, Science, Fochtmann LJ see Bromet EJ; predicting educational Se 879-881 and Fear. Mr 332-333 YagerJ attainment in young adults Gomez R see Garrett A Groctens KP: Oxybutynin Fogel BL see Wexler E (editorial). No 1131-1133 Gong Q see Lui S for antidepressant-induced Foland-Ross LC, Thompson GeierT see Skodol AE Goodyer I see Fairchild G; hyperhidrosis (letter). M1 PM, Sugar CA, Madsen SK, Gejman PV see Levinson DF Wilkinson P 330-331 Shen JK, Penfold C, Ahlf K, Gelenberg AJ see Yager J Goradia D see Prasad KM GROUP Investigators see Rasser PE, Fischer J, Yang Y, Genolini C see Pingault J-B Gordon C, Green MD: Do all Ingason A Townsend J, Bookheimer SY, George MS, Post RM: Daily relapses in schizophrenia Grunebaum H, Cohler BJ: An Altshuler LL: Investigation of left prefrontal repetitive warrant resumption of medi- early study of an interven- cortical thickness abnormal- transcranial magnetic stimu- cation? (letter). Se 987 tion with children of psy- ities in lithium-free adults lation for acute treatment of Gordon SD see Pergadia ML chotic mothers (letter). No with bipolar I disorder using medication-resistant depres- Gorroochurn P see Drake RE 1222-1223 cortical pattern matching. sion (treatment in psychia- Graham BM, Milad MR: The Grunebaum MF see Oquendo My 530-539 try). Ap 356-364 study of fear extinction: MA Fombonne E see Kim YS Geraci M see Blair KS implications for anxiety Guarnaccia J see Rando K Fonagy P see Shedler J Geraedts AS see Cuijpers P disorders. De 1255-1265 Guffon N see Fassier T Franke B see Bralten J; Hoog- Gerber A see Wang 7. GranberrWy see Green MF Guirgis H see McKnight C man M; Ingason A; Poel- Gerber AJ, Kocsis JH, Milrod Granholm E see Swendsen J Gunnell D see Chang S-S mans G BL, Roose SP, Barber JP, Grant BF see Skodol AE Gur RC see Greenwood TA; Franklin DL see Maguire GA Thase ME, Perkins P, Leon Grant JD see Pergadia ML Pinkham AE Freedland KE see Lustman PJ AC: A quality-based review Grant JE, Odlaug BL, Cham- Gur RE see Greenwood TA; Freedman J: bk rev, McGil- of randomized controlled berlain SR: Neurocognitive Pinkham AE christ I: The Master and His trials of psychodynamic response to deep brain Gurling H see Ingason A Emissary: The Divided Brain psychotherapy (reviews and stimulation for obsessive- Gustafsson O see Ingason A and the Making of the Mod- overviews). Ja 19-28 compulsive disorder: a case ern World. Je 655-656 Gerber AJ, Kocsis JH, Milrod report (letter). De 1338-1339 H Freedman Rs ee Brzustowicz BL, Roose SP, Barber JP, Green MD see Gordon C L; Greenwood TA; Levinson Thase ME, Perkins P, Leon Green MF see Greenwood TA Haddad PM see Tiihonen J DF; Pine DS AC: Response to Douglas: Green MF, Schooler NR, Kern Hagan CC see Fairchild G Freedman R, Lewis DA, Studying the efficacy of psy- RS, Frese FJ, Granberry W, Hagerman R: bk rev, Sha- Michels R, Pine DS, Schultz chodynamic psychotherapy Harvey PD, Karson CN, Pe- piro BK, Accardo PJ, eds: SK, Tamminga CA: 2011 (letter). Je 649-650 ters N, Stewart M, Seidman Neurogenetic Syndromes: in review (editorial). De Gershon ES, Alliey-Rodriguez LJ, Sonnenberg J, Stone WS, Behavioral Issues and Their 1241-1244 N, Liu C: After GWAS: Walling D, Stover E, Marder Treatment. Fe 216-217 Am | Psychiatry 168:12, December 2011 ajp.psychiatryonline.org 1355 ANNUAL AUTHOR INDEX Hakonarson H see Levinson Henriksson R see Dong L Hurford G see Fairchild G alcohol drinking. Mr 265-2Q775n LF Hermann D see Koopmann A Hurst D, Loeffler G, McLay (correction, Jy 756) Hallmayer J see Thompson WK Hermida AP see Maixmer DF R: Psychosis associated with Jones L see Breen G Hamer RH see Stroup TS Hershfield B: Report of synthetic cannabinoid ago- Jones PB see Clarke MC Hamilton SP: A new lead from the Speaker (off acts). Se nists: a case series (letter). Joshi KG see Romo CA genetic studies in depressed 1001-1002 Oc 1119 siblings: assessing studies of Hicks MH-R: Mental health Husain MM see Maixmer DF; K chromosome 3 (reviews and screening and coordination Rush AJ overviews). Au 783-789 of care for soldiers deployed Huttunen M see Clarke MC Kadison R: bk rev, Kay J, HansenT see Ingason A to Iraq and Afghanistan Hyman SE: Grouping diagno- Schwartz V, eds: Mental Hardiman G see Greenwood (editorial). Ap 341-343 ses of mental disorders by Health Care in the College TA Hirschfeld RMA: Deep brain their.common risk factors Community. Oc 1123 Hardy P see Gressier F stimulation for treatment-re- (editorial). Ja 1-3 Kahn MW: Palliative psycho- Harkavy-Friedman J see sistant depression (editorial) therapy (introspection). Se Oquendo MA My 455-456 888-889 Harned MS, Rizvi SL, Linehan Ho A see Chow EWC Kalali AH see Meltzer HY MM: Response to Nepon, Hodges BD see Law SF IMAGEN Consortium see Kan C see Hoogman M Pagura, Sareen: Study limita- Hoek HW see VelingW Peters J Kane JM see Strom BL tions in report of suicidal Hogan MF see Essock SM Ingason A, Kirov G, Giegling I, Kaprio J see Pergadia ML behavior among women Hoge CW see Warner CH Hansen T, Isles AR, Jakobsen Karadurmus N see Naharci MI with co-occurring PTSD and Hollon N see Blair KS KD, Kristinsson KT, le Roux Karolewicz B see Deschwan- borderline personality disor- Holmans PA see Levinson DF L, Gustafsson O, Craddock denA der (letter). Mr 328-329 Holsboer F see Denk MC; N, Moller H-J, McQuil- Karp J see Aizenstein HJ Hartley S see Quera-Salva M-A Zimmermann P lin A, Muglia P, Cichon S, Karpf RD see Shin LM Hartmannn L: bk rev, Ham- Homan P, Kindler J, Feder- Rietschel M, Ophoff RA, Karson CN see Green MF burg D: Preventing Geno- spiel A, Flury R, Hubli D, Djurovic S, Andreassen OA, Kathmann Ns ee Riesel A cide: Practical Steps Toward Hauf M, Dierks T: Muting the Pietilainen OPH, Peltonen Katona C see Cooper C Early Detection and Effective voice: a case of arterial spin L, Dempster E, Collier DA, Kaufmann C see Riesel A Action (revised and updat- labeling-monitored transcra- St. Clair D, Rasmussen HB, Kavelaars A see van Zuiden M ed). Se 992 nial direct current stimula- Glenthoj Y, Kiemeney LA, Keefe RSE see Vigen CLP Harvey A, Kornstein SG: De- tion treatment of auditory Franke B, Tosato S, Bonetto Keller J see Garrett A termination of premenstrual verbal hallucinations (letter). C, Saemundsen E, Hreidars- Keller MB see Fiedorowicz JG symptom exacerbations Au 853-854 (corrections, Se son SJ, GROUP Investiga- Keller MC see Duncan LE (letter). Se 989 991; No 1223) tors, N6then MM, Gurling Kelly R see Garrett A Harvey PD see Green MF Hong K-I see Rando K H, O’Donovan MC, Owen Kelsoe JR see Greenwood TA Harvey PD, Raykov T, Twam- Hoogman M, Aarts E, Zwiers MJ, Sigurdsson E, Petersson Kelvin R see Wilkinson P ley EW, Vella L, Heaton RK, M, Slaats-Willemse D, Naber H, Stefansson H, Rujescu Kemp GJ see LuiS Patterson TL: Validating the M, Onnink M, Cools R, Kan D, Stefansson K, Werge T: Kendler KS see Levinson DF measurement of real-world C, Buitelaar J, Franke B: Ni- Maternally derived micro- Kendler KS, Aggen SH, Knud- functional outcomes: phase | tric oxide synthase genotype duplications at 15q11-q13: sen GP, Roysamb E, Neale results of the VALERO study. modulation of impulsivity implication of imprinted MC, Reichborn-Kjennerud No 1195-1201 and ventral striatal activity genes in psychotic illness. Ap T: The structure of genetic Hasin DS see Skodol AE in adult ADHD patients and 408-417 and environmental risk Hasler G see Deschwanden A healthy comparison subjects. Ising M see Zimmermann P factors for syndromal and Hasnain M see Vieweg WVR Oc 1099-1106 Isles AR see Ingason A subsyndromal common Hauf M see Homan P Horga G see Marsh R Itterman Bs ee Peters J DSM-IV axis I and all axis II Haukka Js ee Tiihonen J Hosanagar A see MattaiA disorders. Ja 29-39 Haws CA see Kim N Howes OD, Bose SK, Turk- J Kennedy SH, Giacobbe P, Heath AC see Pergadia ML heimer F, Valli I, Egerton A, Rizvi SJ, Placenza FM, Nishi- Heaton RK see Harvey PD Valmaggia LR, Murray KM, Jackson C see Essock SM kawa Y, Mayberg HS, Lozano Heijnen CJ see van Zuiden M McGuire P: Dopamine syn- Jacobs Ms ee Blair KS AM: Deep brain stimula- Heins M, Simons C, Lataster thesis capacity before onset Jakobsen KD see Ingason A tion for treatment-resistant T, Pfeifer S, Versmissen D, of psychosis: a prospective Januzzi JL see Mukherji EH depression: follow-up after 3 Lardinois M, Marcelis M, '8F|-DOPA PET imaging Jardri R, Pouchet A, Pins D, to 6 years. My 502-510 Delespaul P, Krabbendam study. De 1311-1317 Thomas P: Cortical activa- Kern RS see Green MF L, van Os J, Myin-Germeys Hreidarsson SJ see Ingason A tions during auditory verbal Kernberg O see Shedler J I: Childhood trauma and Hsiao JK see Vigen CLP hallucinations in schizo- Keshavan MS see Prasad KM psychosis: a case-control Hsu E see Drake RE phrenia: a coordinate-based Keskitalo-Voukko K see Per- and case-sibling comparison Huang X see Law SF; Lui S meta-analysis. Ja 73-81 gadia ML across different levels of Hubbeling DAA: Alternative Javors MA see Johnson BA Kessler RM see Woodward ND genetic liability, psychopa- explanation for fMRI find- Joffe H see Dias RS Keyes KM see Skodol AE thology, and type of trauma ings in social phobia (letter). Johayem A see Deschwanden Khlif H see Gressier F De 1286-1294 My 551 A Kiefer F see Koopmann A Heinssen R see Addington J Huber CG see Agorastos A Johnson B: Response to Kiemeney LA see Ingason A Heinz A see PetersJ Hubli D see Homan P Miiller, Banas: Disulfiram: Kiluk BD, Sugarman DE, Heldt SA see Andero R HuddyV see Wykes T an anticraving substance? Nich C, Gibbons CJ, Martino Hellemann GS see Subotnik Hughes CW: Objective as- (letter). Ja 98-99 S, Rounsaville BJ, Carroll KL sessment of suicide risk: Johnson BA, Ait-Dauod N, KM: A methodological anal- Helmer DA see Dodrill CL significant improvements in Seneviratne C, Roache JD, ysis of randomized clinical Henders AK see Pergadia ML assessment, classification, Javors MA, Wang X-Q, Liu L, trials of computer-assisted Henn FA: Dopamine: a marker and prediction (editorial). De Penberthy JK, DiClemente therapies for psychiatric of psychosis and final com- 1233-1234 CC, Li MD: Pharmacogenetic disorders: toward improved mon driver of schizophrenia Hughes CW see Wickrama- approach at the serotonin standards for an emerging psychosis (editorial). De ratne P transporter gene as a method field (reviews and over- 1239-1240 Hughes KC see Shin LM of reducing the severity of views). Au 790-799 1356 ajp.psychiatryonline.org AmJ Psychiatry 168:12, December 2011 ANNUAL AUTHOR INDEX Kim N, Mickelson JB, Brenner LatasterT see Heins M tion with schizophrenia. De Maguire GA, Franklin DL, BE, Haws CA, Yurgelun-Todd Latham PK see Anton RF 1318-1325 Kirsten J: Asenapine for the DA, Renshaw PF: Altitude, Lathrop M see Dong L; Li MD see Johnson BA treatment of stuttering: an gun ownership, rural areas, Peters J Li R see Woodward ND analysis of three cases (let- and suicide. Ja 49-54 Laucht M see Dong L Lieb R see Zimmermann P ter). Je 651-652 Kim N, Yurgelun-Todd DA, LaVange LM see Stroup TS Lieberraan JA see Roberts CE; Maia TV see Wang Z Renshaw PF: Response to Lave JR see Garfield RL Streup TS Maier W see Breen G Aub in, Berlin, Reynaud: Cur- Law SF, Liu P, Hodges BD, Lieberman JA, Stroup TS: The Maixner DF, Hermida AP, Hu- reiit smoking, hypoxia, and Shera W, Huang X, Zaheer NIMH-CATIE schizophrenia sain MM, Rudowski MR, Reti suicide (letter). Mr 326-327 J, Links PS: Introducing study: what did we learn? IM: Succinylcholine short- Kim S-J see Kim YS psychiatry to rural physi- (commentary). Au 770-775 age and electroconvulsive Kim Y-K see Kim YS cians in China: an innovative Lieberman JA, Winstead D: therapy (letter). Se 986-987 Kim YS, Leventhal BL, Koh education project (education The Council on Research and Majestic C see Blair KS Y-J, Fombonne E, Laska E, in psychiatry). De 1249-1254 Quality Care (off acts). Fe Makkinje R see Bralten J Lim E-C, Cheon K-A, Kim Lawlor DA see McGrath JJ 225-226 Malek M see Shaw P S-J, Kim Y-K, Lee HK, Song Lazignac C see Allen MH Light GA see Greenwood TA Malloy E see Wickramaratne P D-H, Grinker RR: Prevalence Lazzeroni LC see Greenwood Lim E-C see Kim YS Mann JJ see Oquendo MA; of autism spectrum disorders TA Linehan MM see Harned MS Posner K in a total population sample. Le Foll B see Lev-Ran S Links PS see Law SF Marcelis M see Heins M Se 904-912 le Roux L see Ingason A Linszen D see Rietdijk J Marconi S, Rizzo G, Capellari Kindler J see Homan P Le Strat Y see Lev-Ran S Lipsitt DR: Moments of (in) S, Scaglione C, Cortelli P, King C see Wickramaratne P Lebowitz BD see Vigen CLP decision (introspection). Au Martinelli P, Bonazza S: Eat Kirov G see Ingason A Lee H-J see Beevers CG 776-777 ing disorder as a psychiatric Kirsten J see Maguire GA Lee HB: My father’s shoes (in- Liu C see Gershon ES onset of juvenile Hunting Klahr KW see Marsh R trospection). Oc 1031-1032 Liu F see Martinez D ton’s disease (letter). Oc Kleber HD see Martinez D Lee HK see Kim YS Liu JZ see Pergadia ML 1120-1121 Klein RG: Thinning of the ce- Leibenluft E see Biair KS Liu L see Johnson BA Marcus MD: bk rev, Karasu rebral cortex during develop- Leibenluft E: Severe mood Liu P see Law SF SR, Karasu TB: The Gravity ment: a dimension of ADHD dysregulation, irritability, Liu S, Wu Q, Qiu L, Yang of Weight: A Clinical Guide (editorial). Fe 111-113 and the diagnostic bound- X, Kuang W, Chan RCK, to Weight Loss and Mainte- Knight J see Breen G aries of bipolar disorder in Huang X, Kemp GJ, Mech- nance. Je 654 Knudsen GP see Kendler KS youths (reviews and over- elli A, Gong Q: Resting-state Marcus RM, Sanchez R, Frost Kocsis JH see Brody B; Gerber views). Fe 129-142 functional connectivity in M, McQuade RD: Aripipra- AJ Leon AC see Brody B; Fiedoro- treatment-resistant depres- zole adjunctive to antide- Koh Y-J see Kim YS wicz JG; Gerber AJ sion. Je 642-648 pressant therapy (letter). Fe Koopman A, von der Goltz Leon DA see Clarke MC Liu X see Andero R; Li M 211 C, Hermann D, Kiefer F: Leonard S see Greenwood TA Liverpool M see Shaw P Marder S see Green MF; Sub- Propofol addiction initiated Leonardi-Essmann F see Livingston G see Cooper C otnik KL by anesthetic use (letter). Fe Dong L Lock J, Garrett A, Beenhakker Mark MH see Dobkin RD 211-212 Lepri B see Viguera AC J, Reiss AL: Aberrant brain Mark TL, Gibson TM, Mc- Korelitz K see Blair KS Leskov I see Mukherji EH activation during a response Guigan K, Chu BC: Response Korhonen P see Tiihonen J Leslie DL see Druss BG inhibition task in adolescent to Correa: Limitationosf Korhonen T see Pergadia ML Lesser IM see Rush AJ eating disorder subtypes. Ja retrospective research (let- Kornstein SG see Rush AJ Lev-Ran S, Le Strat Y, Le Foll 55-64 ter). Ap 437 Korszun A see Breen G B: Impact of hypertension Loebel A see Meltzer HY Markowitz JC see Cuijpers P Kosten TR see Dodrill CL and body mass index on Loeffler G see Hurst D Markowitz JC, Milrod BL: The Kosten TR: Stress and addic- quality of life in schizophre- Lomax JW, Kripal JJ, Parga- importance of responding to tion (editorial). Je 566-5687 nia (letter). My 552-553 ment KI: Perspectives on negative affect in psycho- Kotov R see Bromet EJ Leventhal BL see Kim YS “sacred moments” in psycho- therapies (education in Koukopoulos AE see Viguera Levinson DF, Duan J, Oh S, therapy (case conf). Ja 12-18 psychiatry). Fe 124-128 AC Wang K, Sanders AR, Shi J, Loth E see Peters J Marks DJ see Solanto MV Krabbendam L see Heins M Zhang N, Mowry BJ, Olincy Loughead J see Pinkham AE Marsh AA see Finger EC Kring AM see Ursu S A, Amin F, Cloninger CR, Loukola A see Pergadia ML Marsh R see Wang Z Kripal JJ see Lomax JW Silverman JM, Buccola NG, Lourdusamy A see Dong L Marsh R, Horga G, Wang Z, Kristinsson KT see Ingason A Byerley WF, Black DW, Kend- Lozano AM see Kennedy SH Wang P, Klahr KW, Berner KuanWg see LuiS ler KS, Freedman R, Dud- Lu L see Zhang X-l LA, Walsh BT, Peterson BS: Kumar D see Martinez D bridge F, Pe’er I, Hakonar- Luo X see LiM An fMRI study of self-regu- Kupfer DJ, Regier DA: Neu- son H, Bergen SE, Fanous Lustman PJ, Svrakic DM, latory control and conflict roscience, clinical evidence, AH, Holmans PA, Gejman Freedland KE: Preventing resolution in adolescents and the future of psychiatric PV: Copy number variants pain medication depen- with bulimia nervosa. No classification in DSM-5 in schizophrenia: confirma- dence (letter). Oc 1118 1210-1220 (commentary). Jy 672-674 tion of five previous findings Luther JF see Rush AJ Martin A see Azad A Kurian BT see Rush AJ and new evidence for 3q29 Lyketsos CG see Spencer L; Martin NG see Pergadia ML Kwon JS see Arias SA microdeletions and VIPR2 Vigen CLP Martinelli P see Marconi S duplications. Mr 302-316 Lyketsos K see Cooper C Martinez D, Carpenter KM, L Lewis CM see Breen G Liu FE, Slifstein M, Broft A, Lewis DA see Curley AA; M Friedman AC, Kumar D, Lafer B see Dias RS Freedman R Van Heertum K, Kleber HD, Lalonde F see Mattai A Li C-SR see Rando K Maas Ms ee van Zuiden M Nunes E: Imaging dopamine Lardinois M see Heins M Li M, Luo X, Xiao X, Shi L, MacGregor S see Pergadia ML transmission in cocaine de- LaRusso EM: Happy Mother's Liu X, Yin L, Diao H, Su B: Mack WJ see Vigen CLP pendence: link between neu- Day, with love from the Allelic differences between Macklin ML see Shin LM rochemistry and response to ABPN (introspection). My Han Chinese and Europeans Madden PAF see Pergadia ML treatment. Je 634-641 464465 for functional variants in Madsen SK see Foland-Ross Martino S see Kiluk BD Laska E see Kim YS ZNF804A and their associa- LC Martinot J-L see Peters J AmJ Psychiatry 168:12, December 2011 ajp.psychiatryonline.org 1357 ANNUAL AUTHOR INDEX Martis B: Cracking the code: opment of obsessive-com- Treatment of Opioid Depen- F dopamine signaling in pulsive disorder following dence. Je 654-655 cocaine dependence (edito- a pineal germinoma: a case Ng M see Breen G Page A see Chang S-S rial). Je 572-575 report (letter). My 550-551 Ng P see Finger EC Pagura J see Nepon J Mataix-Cols D see Nakao T Moffitt TE see Arseneault L; Nich C see Kiluk BD Pancholi KM see Prasad KM Matejkowski J, Cullen S, Solo- Zimmermann P Nielsen PR see Benros ME Papmeyer M see Gillan CM mon P: Comment on the Mogul KM: Report of the Elec- Nierenberg AA see Dias RS; Parellada M: bk rev, Hollander association of stigma with tions Committee (off acts). Rush AJ E, Kolevzon A, Coyle JT, eds: violence (letter). Jy 749 Se 1004 NimgaonkaVrL see Prasad Textbook of Autism Spec- Mattai A, Hosanagar A, Mojtabai R see Comer JS KM trum Disorders. My 554-555 Weisinger B, Greenstein D, Miller H-J see Ingason A Nishikawa Y see Kennedy SH Pargament KI see Lomax JW Stidd R, Clasen L, Lalonde F, Monteggia LM: Toward neuro- Nocon A see Zimmermann P Park S see Woodward ND Rapoport J, Gogtay N: Hip- trophin-based therapeutics Nordentoft M see Benros ME Parker GB: bk rev, Davidson J: pocampal volume develop- (editorial). Fe 114-116 Norgaard-Pedersen B see Downing Street Blues: A His- ment in healthy siblings of Montgomery GW see Pergadia Pedersen MG tory of Depression and Other childhood-onset schizophre- ML Néthen MM see Ingason A Mental Afflictions in British nia patients. Ap 427-435 Morein-Zamir S see Gillan CM Nuechterlein KH see Green- Prime Ministers. Jy 753-754 Mayberg HS see Kennedy SH Morris DW see Rush AJ wood TA; Subotnik KL Parker JR see Warner CH McEvoy JP see Covell NH; Es- Mors O see Breen G Nunes E see Martinez D Parsey RV see Oquendo MA sock SM; Stroup TS Mortensen PB see Benros ME; Nurnberger J: bk rev, Coons Passamonti L see Fairchild G McGlashan TH see Addington Pedersen MG; Petersen L PM, Bowman ES: Psychia- Patel M see Aizenstein HJ J; Woods SW Mortenson LY see Roberts CE try in Indiana: the First 175 Patel MX see Tiihonen J McGrath JJ, Lawlor DA: The Mowry BJ see Levinson DF Years. Se 995-996 Patterson TL see Harvey PD search for modifiable risk Mrazek DA: bk rev, Shaw RJ, Nussbaum A, Thurstone Pauls DL see Poelmans G factors for schizophrenia DeMaso DR, eds: Textbook C, Binswanger I: Medical Paus T see Peters J (editorial). De 1235-1238 of Pediatric Psychosomatic marijuana use and suicide Payne J: Bipolar disorder in McGuffin P see Breen G Medicine. Ap 442-443 attempt in a patient with women with premenstrual McGuigan K see Mark TL Muglia P see Breen G; Ingason major depressive disorder exacerbation (editorial). Ap McGuire P see Howes OD A (case conf). Au 778-781 344-346 McGurk SR see Wykes T Mukherji EH, Bauer LK, Les- Nussbaum AM see Stroup TS Pedersen CB see Pedersen McKnight C, Guirgis H, Voto- kov I, Januzzi JL, Tanev KS: MG; Petersen L lato N: Clozapine rechal- Safety of antipsychotics in Oo Pedersen MG, Stevens H, lenge after excluding the the setting of QTc prolon- Pedersen CB, Norgaard- high-risk clozapine-induced gation: the utility of the JT O’Brien CP: Adapting treat- Pedersen B, Mortensen agranulocytosis genotype of index (letter). Se 990-991 ment to patient problems PB: Toxoplasma infection HLA-DQB1 6672GT>C (let- Miiller CA, Banas R: Disul- (editorial). Jy 670-671 and later development of ter). Oc 1120 firam: an anticraving sub- Occhiogrosso M see Wender P schizophrenia in mothers. McLaughlin D see Carrién RE stance? (letter). Ja 98 Odlaug BL see Grant JE Au 814-821 McLay R see Hurst D Murphy Ts ee Barglow P O’Donovan MC see Ingason A Peele R: Report of the Sec- McQuade RD see Marcus RM Murray RM see Clarke MC; Ogasa M see Meltzer HY retary: actions of the Board McQuillin A see Ingason A Howes OD Oh S see Levinson DF of Trustees (off acts). Se Mechelli A see Lui S Murray SS see Greenwood TA O’Hara R see Thompson WK 998-999 Mediand SE see Pergadia ML Myin-Germeys I see Heins M Oldham JM: Response to Pe’er I see Levinson DF Meltzer HY, Cucchiaro J, Myrick H see Anton RF Presidential Address. Oc Peltonen L see Ingason A Silva R, Ogasa M, Phillips D, 1026-1028 Penberthy JK see Johnson BA Xu J, Kalali AH, Schweizer N Olfson M see Comer JS Penfold C see Foland-Ross LC E, Pikalov A, Loebel A: Olincy A see Greenwood TA; Penninx BW see Duivis HE; Lurasidone in the treatment Na BY see Duivis HE Levinson DF Pergadia ML of schizophrenia: a random- Naber M see Hoogman M Ongur D: bk rev, Stroup TS, Pergadia ML, Glowinski AL, ized, double-blind, placebo- Naharci MI, Karadurmus N, Lieberman JA, eds: Antipsy- Wray NR, Agrawal A, Sac- and olanzapine-controlled Demir O, Bozoglu E, Ak M, chotic Trials in Schizophre- cone SF, Loukola A, Broms trial. Se 957-967 Doruk H: Fatal hepatotox- nia: The CATIE Project. Mr U, Korhonen T, Penninx Melvin GA see Posner K icity in an elderly patient 334 BWJH, Grant JD, Nelson EC, Menz M see Peters J receiving low-dose quetia- Onnink M see Hoogman M Henders AK, Schrage AJ, Menza M see Dobkin RD pine (letter). Fe 212-213 Ophoff RA see Ingason A Chou Y-L, Keskitalo-Vuokko Merrill DB see Roberts CE Nakao T, Radua J, Rubia K, Oquendo MA see Posner K K, Zhu Q, Gordon SD, Vink Michels R see Freedman R; Mataix-Cols D: Gray matter Oquendo MA, Galfalvy HC, JM, de Geus EJC, MacGregor Shedler J volume abnormatities in Currier D, Grunebaum MF, S, Liu JZ, Willemsen G, Mickelson JB see Kim N ADHD: voxel-based meta- Sher L, Sullivan GM, Burke Medland SE, Boomsma DI, Middleton L see Breen G analysis exploring the effects AK, Harkavy-Friedman J, Montgomery GW, Rice JP, Milad MR see Graham BM; of age and stimulant medica- Sublette ME, Parsey RV, Goate AM, Heath AC, Kaprio Shin LM tion (reviews and overviews). Mann JJ: Treatment of sui- J, Martin NG, Madden PAF: Miller CA see Surman GBH No 1154-1163 cide attempters with bipolar A 3p26-3p25 genetic linkage Milofsky JE: bk rev, Lazar SG, Neale MC see Kendler KS disorder: a randomized clini- finding for DSM-IV major ed: Psychotherapy Is Worth Nelson EC see Pergadia ML cal trial comparing lithium depression in heavy smoking It: A Comprehensive Review Nepon J, Pagura J, Sareen J: and valproate in the preven- families. Au 848-852 of Its Cost-Effectiveness. Ja Study limitations in report tion of suicidal behavior. Oc Perkins DO see Addington J; 102-103 of suicidal behavior among 1050-1056 Stroup TS Milrod BL see Gerber AJ; women with co-occurring O’Reardon JP see Rosenthal Perkins P see Gerber AJ Markowitz JC PTSD and borderline per- LJ Perlis RH: Betting on Mintz J see Subotnik KL sonality disorder (letter). Orr SP see Shin LM biomarkers (editorial). Mr Minzenberg MJ see Ursu S Mr 328 Otero M see Blair KS 234-236 Mital VA, Cannon TD, Newton TF: bk rev, Renner Overton E see Pinkham AE Perlis RH: Hard outcomes: Bearden CE: Response to De JA, Levounis P: Handbook of Owen MJ see Breen G; Inga- clinical trials to reduce sui- Nadai, torch, Alvaro: Devel- Office-Based Buprenorphine sonA cide (editorial). Oc 1009-1011 1358 ajp.psychiatryonline.org AmJ Psychiatry 168:12, December 2011 ANNUAL AUTHOR INDEX Perreau-Lenz S see Dong L Polanczyk G see Arseneault L Recupero PR: The Council on BM: Involuntary movements Perry J see Breen G Poline J-B see Peters J Psychiatry and the Law (off associated with cetirizine use Pescosolido BA: Response to Politi P see Barale A acts). Fe 225 (letter). Au 855 Torrey: The association of Posner K, Brown GK, Stanley Regier DA see Kupfer DJ Roose SP see Gerber AJ stigma with violence (letter). B, Brent DA, Yershova KV, Reginaldi D see Viguera AC Rosenbaum JF: bk rev, Warner Mr 325-326 Oquendo MA, Currier GW, Reichborn-Kjennerud T see J: We've Got Issues: Children Peters J, Bromberg U, Sch- Melvin GA, Greenhill L, Shen Kendler KS and Parents in the Age of neider S, Brassen S, Menz M, S, Mann JJ: The Columbia- Reid ME see Finger EC Medication. Fe 214-215 Banaschewski T, Conrod PJ, Suicide Severity Rating Scale: Reiss AL see Garrett A; Lock J Rosenheck RA see Stroup TS Flor H, Gallinat J, Garavan initial validity and internal Reite M: bk rev, Monti JM, Rosenthal LJ, Goldner WS, H, Heinz A, Itterman B, consistency findings from Pandi-Perumal SR, Méhler O’Reardon JP: T; augmenta- Lathrop M, Martinot J-L, three multisite studies with H, eds: GABA and Sleep: tion in major depressive dis- Paus T, Poline J-B, Robbins adolescents and adults. De Molecular, Functional and order: safety considerations TW, Rietschel M, Smolka M, 1266-1277 Clinical Aspects. Jy 755 (treatment in psychiatry). Oc Stréhle A, Struve M, Loth Post RM see George MS Renner JA see Wise TN 1035-1040 E, Schumann G, Biichel C, Pouchet A see Jardri R Renshaw PF see Kim N Rostov D see Spencer L IMAGEN Consortium: Lower Prasad KM, Eack SM, Goradia Ressler KJ see Andero R Rounsaville BJ see Kiluk BD ventral striatal activation D, Pancholi KM, Keshavan Reti IM see Maixmer DF Roysamb E see Kendler KS during reward anticipation MS, Yolken RH, Nimgaonkar Rewerts C see Denk MC Rubia K see Nakao T in adolescent smokers. My VL: Progressive gray matter Reynaud M see Aubin H-J Rubin JEV: Report of the 540-549 loss and changes in cognitive Reynolds CF III see Aizenstein Membership Committee (off Peters N see Green MF functioning associated with HJ acts). Se 1002-1004 Petersen L, Mortensen PB, exposure to herpes simplex Reynolds RF see Strom BL Rudowski MR see Maixmer DF Pedersen CB: Paternal age at virus 1 in schizophrenia: Rice J see Breen G; Pergadia Ruggero C see Bromet EJ birth of first child and risk of a longitudinal study. Au ML Ruiz P: bk rev, Reznek L: Delu- schizophrenia. Ja 82-88 822-830 Ridinger M see Dong L sions and the Madness of the Peterson BS see Wang Z Preisig M see Breen G Riesel A, Endrass T, Kauf- Masses. Ap 440 Petersson H see Ingason A Preti A see Raballo A mann, Kathmann N: Rujescu D see Ingason A Petty CR see Surman GBH Price J see Aizenstein HJ Overactive error-related Ruparel K see Pinkham AE Pfeifer S see Heins M brain activity as a candidate Rush A, Trivedi MH, Stewart Pfister H see Zimmermann P Q endophenotype for obses- JW, Nierenberg AA, Fava M, Phillips D see Meltzer HY sive-compulsive disorder: Kurian BT, Warden D, Mor- Pies R: The ruined good Qiu L see Lui S evidence from unaffected ris DW, Luther JF, Husain boy (introspection). No Quera-Salva M -A, Hartley S, first-degree relatives. Mr MM, Cook IA, Shelton RC, 1145-1146 Claustrat B, Brugiéres L: Cir- 317-324 Lesser IM, Kornsterin SG, Pietilainen OPH see Ingason cadian rhythm disturbances Rietdijk J, Linszen D, van der Wisniewski SR: Combining A associated with psychiatric Gaag M: Field testing attenu- Medications to Enhance Pilalov A see Meltzer HY symptoms in a patient with a ated psychosis syndrome Depression Outcomes (CO- Pilowsky DJ see Wickrama- pineal region tumor (letter). criteria (letter). No 1221 MED): acute and long-term ratne P Ja 99-100 Rietsche! M see Breen G; outcomes of a single-blind Pine DS see Blair KS; Finger Dong L; Ingason A; Peters J randomized study. Jy EC; Freedman R R Rijpkema M see Bralten J 689-701 Pine DS, Freedman R: Imag- Ring KD see Stroup TS Rush AJ see Wickramaratne P ing a brighter future (edito- Raballo A, Cella M, Preti A: Rizvi SJ see Kennedy SH Ruskin J see Strom BL rial). Se 885-887 The pulse of thought: hemo- Rizvi SL see Harned MS Russo C see Dias RS Pingault J-B, Tremblay RE, dynamics of the brain and Rizzo G see Marconi S Vitaro F, Carbonneau R, mind (image, psych). No Roache JD see Johnson BA Ss Genolini C, Falissard B, Coté 1152-1153 Robbins M: bk rev, Starzl TE: SM: Childhood trajectories of Rabins P see Cooper C The Puzzle People: Memoirs Saccone SF see Pergadia ML inattention and hyperactivity Radant AD see Greenwood TA of a Transplant Surgeon. My Sachs GS see Dias RS and prediction of education- Radua J see Nakao T 556-557 Saemundsen E see Ingason A al attainment in early adult- Rafizadeh N see Roberts CE Robbins TW see Gillan CM; Sahakian BJ see Gillan CM hood: a 16-year longitudinal Ragland JD see Ursu S Peters J Samet S see Drake RE population-based study. No Raine A: An amygdala struc- Roberts C see Wilkinson P Sampson AR see Curley AA 1164-1170 tural abnormality common Roberts CE, Mortenson LY, Samstad E see Spencer L Pinkham AE, Loughead J, Ru- to two subtypes of conduct Merrill DEB, Rafizadeh N, Sanchez R see Marcus RM parel K, Overton E, Gur RE, disorder: a neurodevelop- Smith TE, Lieberman JA: Sanders AR see Levinson DF Gur RC: Abnormal modula- mental conundrum (edito- Successful rechallenge with Sano M see Vigen CLP tion of amygdala activity in rial). Je 569-571 clozapine after eosinophilia Sareen J see Nepon J schizophrenia in response Randall PK see Anton RF (case conf). No 1147-1151 Sasin DS see Drake RE to direct- and averted-gaze Rando K, Hong K-I, Bhag- Robinowitz CB: Carol A Sato M: The short-term effect threat-related facial expres- wagar Z, Li C-SR, Bergquist Bernstein, 137th President, of the recent great earth- sions. Mr 293-301 K, Guarnaccia J, Sinha R: 2010-2011. Oc 1029-1030 quake on the general func- Pins D see Jardri R Association of frontal and Robinson DG: Medication tioning status of psychiatric Pitman RK see Shin LM posterior cortical gray matter adherence and relapse in patients near Tokyo (letter). Placenza FM see Kennedy SH volume with time to alcohol recent-onset psychosis (edi- Je 649 Poelmans G, Pauls DL, Buite- relapse: a prospective study. torial). Mr 240-242 Savin D: bk rev, Niaz U: Wars, laar JK, Franke B: Integrated Fe 183-192 Rodriguez C see Alcon J Insurgencies, and Terror- genome-wide association Rapoport J see Mattai A; Rogers SJ: bk rev, Treffert D: ist Attacks: A psychosocial study findings: identifica- Shaw P Islands of Genius: The Boun- Perspective From the Muslim tion ofa neurodevelopmen- Rasmussen HB see Ingason A tiful Mind of the Autistic, Ac- World. Je 653-654 tal network for attention Rasser PE see Foland-Ross LC quired, and Sudden Savant. Savitz AJ see Avery JD deficit hyperactivity disorder Rauch SL see Eddy KT; Shin Au 860-861 Scaglione C see Marconi S (reviews and overviews). Ap LM Rojas I see Essock SM Schabbing M: bk rev, Janicak 365-377 Raykov T see Harvey PD Romo CA, Joshi KG, Waters PG, Marder SR, Pavuluri MN: AmJ Psychiatry 168:12, December 2011 ajp.psychiatryonline.org 1359 ANNUAL AUTHOR INDEX Principles and Practice of Shi L see LiM Sovago J see Deschwanden A Su B see LiM Psychopharmacotherapy, Shin LM, Bush G, Milad MR, Soyka M see Dong L Sublette ME see Oquendo MA Fifth Edition. Au 861 Lasko NB, Brohawn KH, Spanagel R see Dong L Subotnik KL, Nuechterlein Schatzberg AF see Etkin A; Hughes KC, Macklin ML, Spencer L, Lyketsos CG, KH, Ventura J, Gitlin MJ, Garrett A Gold AL, Karpf RD, Orr SP, Samstad E, Kokey A, Rostov Marder S, Mintz J, Hel- Schechter MA: Nicotine Rauch SL, Pitman RK: Exag- D, Chisolm MS: A suicidal lemann GS, Thornton replacement therapy in gerated activation of dorsal adult in crisis: an unexpected LA, Singh IR: Risperidone the psychiatric emergency anterior cingulate cortex diagnosis of autism spec- nonadherence and return department (editorial). Ap during cognitive interfer- trum disorder (case conf). Se of positive symptoms in the 347-349 ence: a monozygotic twin 890-892 early course of schizophre- Schizophrenia Trials Network study of posttraumatic stress Spencer T see Surman GBH nia. Mr 286-292 see Essock SM; Stroup TS disorder. Se 979-985 St. Clair D see Ingason A Subotnik KL, Nuechterlein Schneck C: Bipolar phenom- Shorter E see Dhossche D Stanley B see Posner K KH, Ventura J, Marder S: Re- enology: have we learned Siever LJ see Greenwood TA Stefansson H see Ingason A sponse to Gordon, Gree: Do all we can learn? (editorial). Sigurdsson E see Ingason A Stefansson K see Ingason A all relapses in schizophrenia Ja 4-6 Silva R see Meltzer HY Steinberg H: A 200th an- warrant resumption of medi- Schneider LS see Vigen CLP Silver JM: bk rev, Steele CM: niversary of academic cation? (letter). Se 987-988 Schneider S see Peters J Whistling Vivaldi: And Other psychiatry (image, psych). Sugar CA see Foland-Ross LC Schooler NR see Covell NH; Clues to How Stereotypes Oc 1033-1034 Sugarman DE see Kiluk BD Essock SM; Green MF Affect Us. My 556 Stern R: bk rev, Danilowitz B: Sullivan A: Report of the Schork NJ see Greenwood TA Silverman JM see Greenwood he Prints of Josef Albers: Speaker-Elect (off acts). Se Schrage AJ see Pergadia ML TA; Levinson DF A Catalogue Raisonné 1002 Schroeder SA: Depression, Simons C see Heins M 1915-1976, Revised Edition. Sullivan GM see Oquendo MA smoking, and heart disease: Sims C see Finger EC De 1344-1345 Sultzer DL see Vigen CLP how can psychiatrists be Singh IR see Subotnik KL Stevens H see Pedersen MG Sun L-I see Zhang X-l effective? (editorial). Se Singh MK: bk rev, Brown TE, Stewart JW see Rush AJ Surman GBH, Biederman J, 876-878 ed: ADHD Comorbidities: Stewart M see Green MF Spencer T, Yorks D, Miller Schultz SK see Devanand DP; Handbook for ADHD Com- Stidd R see Mattai A CA, Petty CR, Faraone SV: Freedman R plications in Children and Stockmeier CA see Deschwan- Deficient emotional Schumann G see Dong L; Adults. My 555 denA self-regulation and adult Peters J Sinha R see Rando K Stone WS see Green MF; attention deficit hyperactiv- Schweizer E see Meltzer HY Skodol A: Response to Adler: Greenwood TA ity disorder: a family risk Scully JH Jr: Report of the Epistemological tension in Storch EA see De Nadai AS analysis. Je 617-623 Medical Director and CEO the future of personality Stover E see Green MF Susser E see VelingW (off acts). Se 1000-1001 disorder diagnosis (letter). Stréhle A see Peters J Svrakic DM see Lustman PJ Seidman LJ see Addington J; No 1222 Strom BL, Eng SM, Faich G, Swartz CM: bk rev, Hersh JK: Green MF; Greenwood TA Skodol AE, Grilo CM, Keyes Reynolds RF, D’Agostino RB, Struck by Living: From De- Selten J-P see VelingW KM, Geier T, Grant BF, Hasin Ruskin J, Kane JM: Com- pression to Hope. Jy 754-755 Seneviratne C see Johnson BA DS: Relationship of person- parative mortality associ- Swartz MS see Stroup TS Seritan AL: bk rev, Kay J: ality disorders to the course ated with ziprasidone and Swendsen J, Ben-Zeev D, Obliquity: Why Our Goals of major depressive disorder olanzapine in real-world Granholm E: Real-time Are Best Achieved Indirectly. in a nationally representative use among 18,154 patients electronic ambulatory De 1342-1343 sample. Mr 257-264 with schizophrenia: the monitoring of substance use Sexson S: The Council on Skodol AE: Revision of the Ziprasidone Observational and symptom expression in Medical Education and personality disorder model Study of Cardiac Outcomes schizophrenia. Fe 202-209 Lifelong Learning (off acts). for DSM-5 (letter). Ja 97 (ZODIAC). Fe 193-201 Swerdlow NR see Greenwood Slaats-Willemse D see Hoog- Strom BL, on behalf of the TA Sharfstein SS: Integrated care man M ZODIAC Investigators: (editorial). No 1134-1135 Slifstein M see Martinez D Response to Vieweg, Has- T Sharp W see Shaw P Smith MJ see Csernansky JG nain: Question regarding Shaw P, Gilliam M, Liver- Smith TE see Roberts CE ziprasidone and QTc interval Tamminga CA see Freedman R pool M, Weddle C, Malek Smolka M see Dong L; Peters J prolongation in the ZODIAC Tamminga CA: When is M, Sharp W, Greenstein D, Smoller JW: Do Antidepres- study (letter). Je 651 polypharmacy an advantage? Evans A, Rapoport J, Giedd sants raise the risk of stroke? Stroup TS see Covell NH; (editorial). Jy 663 J: Cortical development in (editorial). My 457-459 Essock SM; Lieberman JA; Tanenberg-Karant M see typically developing children Snavely A, Chessick C: bk Vigen CLP Bromet EJ with symptoms of hyperac- rev, Hagen R, Turkington D, Stroup TS, McEvoy JP, Ring Tanev KS see Mukherji EH tivity and impulsivity: sup- Berge T, Grawe RW: CBT for KD, Hamer RH, LaVange Tanguay PE: Autism in DSM-5 port for a dimensional view Psychosis: A Symptom-Based LM, Swartz MS, Rosenheck (commentary). No 1142-1144 of attention deficit hyperac- Approach. No 1226-1227 RA, Perkins DO, Nussbaum Tanskanen A see Clarke MC tivity disorder. Fe 143-151 Solanto MV, Wasserstein J, AM, Lieberman JA, for Tariot PN see Vigen CLP Shedler J, Beck AT, Fonagy Marks DJ: Reponse to Wells, the Schizophrenia Trials Taylor M see Tiihonen J P, Gabbard GO, Kernberg Fisher: Meta-cognitive Network: A randomized Telch MJ see Beevers CG O, Michels R, Westen D: therapy without metacogni- trial examining the effec- Thase ME see Gerber AJ Response to Skodol: Revision tion: a case of ADHD (letter). tiveness of switching from Thomas Ps ee Jardri R of the personality disorder Mr 327-328 olanzapine, quetiapine, or Thompson PM see Foland- model for DSM-5 (letter). Ja Solomon DA see Fiedorowicz risperidone to aripiprazole to Ross LC 97-98 JG reduce metabolic risk: Com- Thompson WK, Hallmayer J, Shelton RC see Rush AJ Solomon M see Ursu S parison of Antipsychotics for O’Hara R, Alzheimer’s Dis- Shen JK see Foland-Ross LC Song D-H see Kim YS Metabolic Problems (CAMP). ease Neuroimaging Initia- Shen S see Posner K Sonnenberg J see Green MF Se 947-956 tive: Design considerations Sher L see Oquendo MA Sood AB see Wickramaratne P Stroup TS: What can large for characterizing psychiatric Shera W see Law SF Sorel E: Report of the Com- simple trials do for psychia- trajectories across the lifes- Shi J see Levinson DF; Zhang mittee of Tellers (off acts). try? (editorial). Fe 117-119 pan: application to effects of X-l Se 1004 Struve M see Peters J APOE-e4 on cerebral cortical 1360 ajp.psychiatryonline.org Amj Psychiatry 168:12, December 2011